CLC Calculus Vct Plc

RNS Number:5155R
Clinical Computing PLC
15 February 2002



For Immediate Release                             15 February 2002



                 CLINICAL COMPUTING PLC: CONTRACT GAINS FOR
            CLINICAL VISION PRODUCT AND DATE FOR NEXT FINAL RESULTS

Clinical Computing Plc ("CCL"), which produces leading clinical software
systems, announces that it will report its final results for the year ended 31
December 2001, on Monday, 25th March 2002.  At that time, it will expect to
report turnover for that year in the order of £2.1m.


CCL also announces the following contract gains in the United States, amounting
to $US728,000 (£515,000), from its new Clinical Vision product for the renal
dialysis and transplant markets.  These contracts will be recognized in CCL's
current financial year ending 31 December 2002.


The contract gains are from:


Flushing Hospital, Flushing, New York
A single site installation with plans to expand into a second site.



Cabell Huntington Hospital, Huntington, West Virginia
A newly renovated single site dialysis unit.



Middletown Regional Hospital, Middletown, Ohio
A newly constructed dialysis unit.



The Health Alliance, Cincinnati, Ohio
The combination of The Christ Hospital, The University Hospital, The St. Luke
Hospitals, Jewish Kenwood Hospital and Fort Hamilton Hughes Hospital, all
located in the greater Cincinnati area.

The hospitals will serve as strategic site for Clinical Computing's United
States sales operation, also located in Cincinnati.  In addition, The University
Hospital has purchased the Clinical Vision transplant solution and will soon
integrate both the renal and transplant solutions on one common platform.



Dialysis Centres of Lincoln, Lincoln, Nebraska
Operates 4 dialysis centres in Nebraska and is a current customer utilising
Clinical Computing's RENLStar software.



The above contracts will also deliver $125,000 of new annual maintenance fees to
CCL in addition to the fees noted above.



Commenting, Jack Richardson, Chief Executive Officer, Clinical Computing Plc,
said:

"These contract gains, with respected facilities, validates our strategy and
efforts of the past two years to develop Clinical Vision for multiple clinical
markets while extending our company presence in both the renal dialysis and
transplant markets.  We are now positioned to demonstrate Clinical Vision's
capabilities in clinical areas that we previously did not market.  The US
transplant market alone is estimated at $28 million."







ENDS



For further information please contact:

Jack Richardson, Chief Executive, Clinical Computing Plc    Tel: 001513 651 3803
Joe Marlovits, Finance Director, Clinical Computing Plc Tel: +44 (0)20 8380 4400
Peter Binns/Paul McManus, Binns & Co PR Ltd             Tel: +44 (0)20 7786 9600



                      This information is provided by RNS
            The company news service from the London Stock Exchange

Calculus Vct (LSE:CLC)
Historical Stock Chart
From Jun 2024 to Jul 2024

Calculus Vct (LSE:CLC)
Historical Stock Chart
From Jul 2023 to Jul 2024